OpinionHave not posted here for a long time. I am a long time investor in Antibe. Actually since the IPO. I have hung in and added to the point that I am a large share holder. I have not lost my faith. My observations are as follows:
1. The science and successes have not changed.
2. The process and testing phases are taking too long, at least from an investors perspective. Only an experienced investor in the bio space can judge that accurately.
3. Dan is a steady guy generally, but miss speaks at key times. He needs to be more positive at strategic points.
4. The recent building of the team seems to be really good. We need those additions to do the heavy lifting.
5. The stock price will not significantly move until a catalyst. Typical of small cap stocks.
6. With a catalyst, it can move lots, real fast.
My biggeat fear is that they will require more raises thus diluting the shares. I have seen this in the mining space often.
My conclusion - steady as it goes - a partnership, move to TSX, test success or any other catalyst will move the SP back to over 50 cents in a heart beat.